Evaluation of Clinical Compendia Used for Medicare Part D Coverage Determinations for Off-label Prescribing in Dermatology-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluation of Clinical Compendia Used for Medicare Part D Coverage Determinations for Off-label Prescribing in Dermatology

Published:2019-03-01 Issue:3 Volume:155 Page:315
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Barbieri John S.¹,St Claire Kayla²,Mostaghimi Arash³,Albrecht Joerg⁴⁵

Affiliation:

1. Department of Dermatology, University of Pennsylvania, Philadelphia

2. Medical Student, University of Illinois College of Medicine, Chicago

3. Department of Dermatology, Brigham and Women’s Hospital, Boston, Massachusetts

4. Division of Dermatology, Department of Medicine, J. H. Stroger, Jr, Hospital of Cook County, Chicago, Illinois

5. Department of Dermatology, Rush Medical College, Chicago, Illinois

Publisher

American Medical Association (AMA)

Subject

Dermatology

Link

http:///jamadermatology/article-pdf/155/3/315/17393153/jamadermatology_barbieri_2019_oi_180077.pdf

Reference25 articles.

1. Systematic review: reliability of compendia methods for off-label oncology indications.;Abernethy;Ann Intern Med,2009

2. The NCCN Compendium for Cancer Management: interview with Bill McGivney, PhD.;Am Health Drug Benefits,2008

3. Off-label prescribing in the treatment of dermatologic disease.;Sugarman;J Am Acad Dermatol,2002

4. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.;Ginzler;N Engl J Med,2005

5. Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial.;Williams;Lancet,2017

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The changing landscape of medicare part D coverage: effects of the Inflation Reduction Act (IRA) in dermatology;Drugs & Therapy Perspectives;2024-07-18

2. Unintended Consequences of the Inflation Reduction Act: Clinical Development Toward Subsequent Indications;The American Journal of Managed Care;2024-02-01

3. Management guideline for the off-label use of medicine in China (2021);Expert Review of Clinical Pharmacology;2022-09-11

4. Impact of off‐label use regulations on patient care in dermatology – a prospective study of cost‐coverage applications filed by tertiary dermatology clinics throughout Germany;Journal of the European Academy of Dermatology and Venereology;2022-07-07

5. Regulatory Challenges to Emergency Medicine Procedural Sedation;Annals of Emergency Medicine;2021-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3